172 related articles for article (PubMed ID: 23391636)
21. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.
Hessels D; Klein Gunnewiek JM; van Oort I; Karthaus HF; van Leenders GJ; van Balken B; Kiemeney LA; Witjes JA; Schalken JA
Eur Urol; 2003 Jul; 44(1):8-15; discussion 15-6. PubMed ID: 12814669
[TBL] [Abstract][Full Text] [Related]
22. Intron retention: a common splicing event within the human kallikrein gene family.
Michael IP; Kurlender L; Memari N; Yousef GM; Du D; Grass L; Stephan C; Jung K; Diamandis EP
Clin Chem; 2005 Mar; 51(3):506-15. PubMed ID: 15650036
[TBL] [Abstract][Full Text] [Related]
23. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
Whitman EJ; Groskopf J; Ali A; Chen Y; Blase A; Furusato B; Petrovics G; Ibrahim M; Elsamanoudi S; Cullen J; Sesterhenn IA; Brassell S; Rittenhouse H; Srivastava S; McLeod DG
J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539
[TBL] [Abstract][Full Text] [Related]
24. Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies.
Ricciardelli C; Bianco-Miotto T; Jindal S; Dodd TJ; Cohen PA; Marshall VR; Sutherland PD; Samaratunga H; Kench JG; Dong Y; Wang H; Clements JA; Risbridger GP; Sutherland RL; Tilley WD; Horsfall DJ;
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1755-65. PubMed ID: 20615888
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
26. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
[TBL] [Abstract][Full Text] [Related]
27. PCA3 and PSA gene activity correlates with the true tumor cell burden in prostate cancer lymph node metastases.
Tsaur I; Hennenlotter J; Oppermann E; Munz M; Kuehs U; Stenzl A; Schilling D
Cancer Biomark; 2015; 15(3):311-6. PubMed ID: 25769446
[TBL] [Abstract][Full Text] [Related]
28. PCA3 gene expression in prostate cancer tissue in a Chinese population: quantification by real-time FQ-RT-PCR based on exon 3 of PCA3.
Tao Z; Shen M; Zheng Y; Mao X; Chen Z; Yin Y; Yu K; Weng Z; Xie H; Li C; Wu X; Hu Y; Zhang X; Wang O; Song Q; Yu Z
Exp Mol Pathol; 2010 Aug; 89(1):58-62. PubMed ID: 20114043
[TBL] [Abstract][Full Text] [Related]
29. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
[TBL] [Abstract][Full Text] [Related]
30. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
Laxman B; Morris DS; Yu J; Siddiqui J; Cao J; Mehra R; Lonigro RJ; Tsodikov A; Wei JT; Tomlins SA; Chinnaiyan AM
Cancer Res; 2008 Feb; 68(3):645-9. PubMed ID: 18245462
[TBL] [Abstract][Full Text] [Related]
31. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate.
Henttu P; Lukkarinen O; Vihko P
Int J Cancer; 1990 Apr; 45(4):654-60. PubMed ID: 1691151
[TBL] [Abstract][Full Text] [Related]
32. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
33. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy.
Theodorescu D; Frierson HF; Sikes RA
J Urol; 1999 May; 161(5):1442-8. PubMed ID: 10210369
[TBL] [Abstract][Full Text] [Related]
34. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
[TBL] [Abstract][Full Text] [Related]
35. Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.
van Gils MP; Hessels D; Hulsbergen-van de Kaa CA; Witjes JA; Jansen CF; Mulders PF; Rittenhouse HG; Schalken JA
Prostate; 2008 Aug; 68(11):1215-22. PubMed ID: 18500693
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
37. Tumor expression of human chorionic gonadotropin beta mRNA and prognosis of prostate cancer treated by radical prostatectomy.
Lintula S; Mirtti T; Rannikko A; Bützow A; Lempiäinen A; Stenman J; Stenman UH; Hotakainen K
Scand J Clin Lab Invest; 2019 Oct; 79(6):424-430. PubMed ID: 31294620
[TBL] [Abstract][Full Text] [Related]
38. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
[TBL] [Abstract][Full Text] [Related]
39. The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.
Durand X; Xylinas E; Radulescu C; Haus-Cheymol R; Moutereau S; Ploussard G; Forgues A; Robert G; Vacherot F; Loric S; Allory Y; Ruffion A; de la Taille A
BJU Int; 2012 Jul; 110(1):43-9. PubMed ID: 22221521
[TBL] [Abstract][Full Text] [Related]
40. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors.
de Kok JB; Verhaegh GW; Roelofs RW; Hessels D; Kiemeney LA; Aalders TW; Swinkels DW; Schalken JA
Cancer Res; 2002 May; 62(9):2695-8. PubMed ID: 11980670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
